Related references
Note: Only part of the references are listed.Analysis and identification of novel biomarkers involved in neuroblastoma via integrated bioinformatics
Bo Chen et al.
INVESTIGATIONAL NEW DRUGS (2021)
Serum response factor, a novel early diagnostic biomarker of acute kidney injury
Long Zhao et al.
Aging-US (2021)
Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling
Zhenlin Wang et al.
ONCOGENE (2021)
The relationship between PLOD1 expression level and glioma prognosis investigated using public databases
Lei Tian et al.
PEERJ (2021)
P3H4 Overexpression Serves as a Prognostic Factor in Lung Adenocarcinoma
Xiangfeng Jin et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2021)
Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile
Jean Hoffman-Censits et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Knockdown of P3H4 inhibits proliferation and invasion of bladder cancer
Lin Hao et al.
AGING-US (2020)
Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methods
Roshanak Shams et al.
SCIENTIFIC REPORTS (2020)
PLOD1, a target of miR-34c, contributes to cell growth and metastasis via repressing LATS1 phosphorylation and inactivating Hippo pathway in osteosarcoma
Xiaolin Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target
Yasutaka Yamada et al.
MOLECULAR ONCOLOGY (2019)
Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis
Yejinpeng Wang et al.
FRONTIERS IN ONCOLOGY (2019)
Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
Atif Ali Hashmi et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts
Torben Frostrup Hansen et al.
BRITISH JOURNAL OF CANCER (2018)
mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants
Markus Eckstein et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data
Matteo Giulietti et al.
FRONTIERS IN ONCOLOGY (2018)
Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study
Lars Dyrskjot et al.
EUROPEAN UROLOGY (2017)
Overexpression of COL3A1 confers a poor prognosis in human bladder cancer identified by co-expression analysis
Lushun Yuan et al.
ONCOTARGET (2017)
Role of Non-Coding RNAs in the Etiology of Bladder Cancer
Caterina Gulia et al.
GENES (2017)
Sc65-Null Mice Provide Evidence for a Novel Endoplasmic Reticulum Complex Regulating Collagen Lysyl Hydroxylation
Melissa E. Heard et al.
PLOS GENETICS (2016)
A Case of Ehlers-Danlos Syndrome Type VIA With a Novel PLOD1 Gene Mutation
Ayse Tosun et al.
PEDIATRIC NEUROLOGY (2014)
Lysine post-translational modifications of collagen
Mitsuo Yamauchi et al.
LYSINE-BASED POST-TRANSLATIONAL MODIFICATION OF PROTEINS (2012)
Long-term Cancer-specific Survival in Patients with High-risk, Non-muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review
Sven van den Bosch et al.
EUROPEAN UROLOGY (2011)
Complex humoral immune response against a benign tumor: Frequent antibody response against specific antigens as diagnostic targets
N Comtesse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico proteomics
DK Crockett et al.
PROTEOMICS (2005)
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer
A Fosså et al.
BRITISH JOURNAL OF CANCER (2000)